COMP <GO>
IMNM vs XNCR // REVENUE GROWTH (YOY)
Immunome Inc. (NASDAQ) VS. Xencor Inc. (NASDAQ) • 15-METRIC TALLY: IMNM 1
— XNCR 6
▲ REVENUE GROWTH (YOY) LEADER: XNCR
LAST: $18.29 (-2.50%) • MKT CAP: $2.16B
revenue-growth
-23.20%
LAST: $29.21 (-2.60%) • MKT CAP: $2.17B
revenue-growth
13.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMNM VS. XNCR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IMNM | XNCR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -21.30% | -13.70 | XNCR | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -9.29% | -6.37% | -2.92 | XNCR | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -23.20% | 13.70% | -36.90 | XNCR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 25.03 | 4.32 | +20.71 | IMNM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 4/9 | -1.00 | XNCR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.5 | 68.0 | -28.51 | XNCR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.16B | $2.17B | -$13.6M | XNCR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IMNM REV | XNCR REV | IMNM GROSS % | XNCR GROSS % | IMNM FCF | XNCR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.9M | $125.6M | — | — | -$200.6M | -$138.3M |
| FY 2024 | $9.0M | $110.5M | — | — | -$118.0M | -$208.3M |
| FY 2023 | $14.0M | $174.6M | — | — | -$7.6M | -$77.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMNM // BETA —
XNCR // BETA —